Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the ...

Merck (MRK) closed at $110.42 in the latest trading session, marking a +1.92% move from the prior day. The stock outperformed ...

It was revealed in a recent SEC filing that Chirfi Guindo, Chief Marketing Officer at Merck & Co (NYSE: MRK) made a ...

Investors are apparently taking bets on when Revolution will be acquired. A handful of pharmas could be interested as Merck ...

Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. On January 20, TD Cowen ...

Merck & Co shares are trading up 1.19% at $107.25 at the time of this writing on Thursday morning. About Merck & Co. Merck makes pharmaceutical products to treat several condition ...

Venture investors are adopting a more aggressive mindset heading into 2026, while Merck, Moderna and Summit are all approaching crucial trial readouts.

There might be massive upside ahead for these drugmakers.

Bristol Myers Squibb, GSK and Merck are contributing drug ingredients as part of their deals with the White House but are ...

Merck headquarters in Rahway, NJ. RAHWAY, N.J. – You can’t say you weren’t warned. Last year Merck, the giant pharmaceutical company with multiple facilities in eastern Pennsylvania and New Jersey, ...

By Arasu Kannagi Basil Jan 28 (Reuters) - Eikon ‍Therapeutics, headed by Merck veteran Roger Perlmutter, is targeting a valuation of up to $908.2 million in its initial public offering in the United ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The oncology segment alone is expected to generate $232 billion in sales this year.